An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT01574326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 2-Week, Randomized, Placebo-Controlled, Fixed Dose Period Followed by a 6-Month, Single-Arm, Open-Label, Dose Titration Period Study to Investigate the Efficacy and Safety of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Objective: In hyperphosphatemic pediatric participants with chronic kidney disease (CKD) to * Evaluate the safety and tolerability of sevelamer carbonate * Evaluate the efficacy of sevelamer carbonate on the control of serum phosphorus
Study identification
- NCT ID
- NCT01574326
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2012 (Type not available)
- Primary completion
- Jun 2015 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Jul 25, 2016
2012 – 2015
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 8003 | Birmingham | Alabama | 35205 | — |
| Investigational Site Number 8005 | Birmingham | Alabama | 35205 | — |
| Investigational Site Number 8013 | Los Angeles | California | 90024 | — |
| Investigational Site Number 8014 | San Francisco | California | 94143 | — |
| Investigational Site Number 8025 | Orlando | Florida | 32806 | — |
| Investigational Site Number 8007 | Atlanta | Georgia | 30322 | — |
| Investigational Site Number 8019 | Iowa City | Iowa | — | — |
| Investigational Site Number 8012 | Baltimore | Maryland | 21287 | — |
| Investigational Site Number 8008 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 8020 | Detroit | Michigan | 48201 | — |
| Investigational Site Number 8022 | Kansas City | Missouri | 64108 | — |
| Investigational Site Number 8023 | St Louis | Missouri | 63110 | — |
| Investigational Site Number 8017 | Livingston | New Jersey | 07039 | — |
| Investigational Site Number 8018 | Buffalo | New York | 14222 | — |
| Investigational Site Number 8009 | Greenville | North Carolina | 27834 | — |
| Investigational Site Number 8010 | Portland | Oregon | 97201-3098 | — |
| Investigational Site Number 8011 | Philadelphia | Pennsylvania | 19104 | — |
| Investigational Site Number 8026 | Dallas | Texas | 75390 | — |
| Investigational Site Number 8016 | Houston | Texas | 77030 | — |
| Investigational Site Number 8001 | San Antonio | Texas | 78229 | — |
| Investigational Site Number 8002 | Charlottesville | Virginia | 22908 | — |
| Investigational Site Number 8027 | Richmond | Virginia | 23298-0034 | — |
| Investigational Site Number 8006 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01574326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2016 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01574326 live on ClinicalTrials.gov.